ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Nurse-Led Case Management for Diabetes and Cardiovascular Disease Patients With Depression

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Nurse-Led Case Management for Diabetes and Cardiovascular Disease Patients With Depression
Official Title  Randomized Trial of Liaison Psychiatry in Primary Care
Brief Summary

This study will evaluate the effectiveness of a nurse-led case management intervention in improving disease control and depression symptoms in adults with diabetes and/or heart disease who are also depressed.

Detailed Description

Depression is a serious medical illness that has been associated with increased risk for heart disease and diabetes. Depression may negatively impact aspects of self-care that are required to effectively manage such long-term diseases. In depressed people who have heart disease and/or diabetes, treatment for depression appears to result in only limited improvements in depression symptoms and no improvements in heart disease and diabetes symptoms. An integrated treatment approach may be more effective in improving all three conditions. This study will evaluate the effectiveness of a nurse-led case management intervention in improving disease control and depression symptoms in adults with diabetes and/or heart disease who are also depressed.

Participants in this single-blind study will be randomly assigned to take part in the case management intervention or receive usual care. All participants will attend 10 study visits and receive 4 follow-up phone calls over 24 months. At 5 of the study visits, measurements of height, weight, waist size, and blood pressure will be taken. At the other 5 study visits, blood and urine samples will be taken. Participants will be asked not to eat for 8 hours before providing blood samples at 3 of the visits. During follow-up phone calls participants will answer various questions.

The case management intervention will entail two to eight additional visits with a trained nurse at the clinic or by telephone. Participants in this group will receive educational materials about how to manage diabetes and/or heart disease and stress or depression. Nurses will also provide guidance and support in managing medications, phone calls to check participants' progress, and assistance in setting personal goals and in managing physical health problems and symptoms of depression or stress. Outcomes will be measured at Months 6, 12, 18, and 24.

Study Phase
Study Type  Interventional
Study Design  Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study
Primary Outcome Measure  Score on the Symptom Checklist-20 (SCL-20) depression scale [ Time Frame: Measured at Months 6, 12, 18, and 24 ] [ Designated as safety issue: No ]
Percentage on disease control indices [ Time Frame: Measured at Months 6, 12, 18, and 24 ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Functional impairment [ Time Frame: Measured at Months 6, 12, 18, and 24 ] [ Designated as safety issue: No ]
Adherence to prescribed medications [ Time Frame: Measured at Months 6, 12, 18, and 24 ] [ Designated as safety issue: No ]
Health care costs [ Time Frame: Measured at Months 6, 12, 18, and 24 ] [ Designated as safety issue: No ]
Condition  Depression
Intervention  Behavioral: Nurse-led case management
Behavioral: Treatment as usual
MEDLINE PMIDs 15466678
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  300
Start Date  May 2007
Completion Date June 2009
Eligibility Criteria 

Inclusion Criteria:

  • Diagnosis of diabetes and/or heart disease
  • Poor disease control (defined as an HbA1c level of at least 8.5%, blood pressure greater than 140/90 mm Hg, LDL cholesterol greater than 130 mg/dL)
  • Diagnosis of major depressive disorder

Exclusion Criteria:

  • History of psychosis
  • At high risk for suicide
  • Cognitive impairment
  • Current alcohol or substance abuse disorder
  • Does not own a telephone
  • Currently seeking psychiatric care
  • Pregnant or breastfeeding
  • Currently enrolled in a Group Health Cooperative disease management program
  • Terminal illness
  • Plans to leave Group Health Cooperative in less than a year
  • Does not speak English
Gender Both
Ages 18 Years to 80 Years
Accepts Healthy Volunteers No
Contacts ††
Contact: Wayne J. Katon, MD     206-543-7177     wkaton@u.washington.edu    
Contact: Michael Von Korff, ScD     206-287-2874     vonkorff.m@ghc.org    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00468676
Organization ID R01 MH41739
Secondary IDs †† DSIR 82-SEPC
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Wayne J. Katon, MD     University of Washington    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date April 2008
First Received Date  May 1, 2007
Last Updated Date April 1, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers